- Home
- JAGX vs MKZR Comparison
JAGX vs MKZR Comparison
Compare JAGX & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JAGX | MKZR |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 4.6M |
| IPO Year | 2014 | 2012 |
Fundamental Metrics
Financial Performance| Metric | JAGX | MKZR |
|---|---|---|
| Price | $0.31 | $1.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | ★ 247.4K | 11.7K |
| Earning Date | 04-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,511,000.00 | ★ $22,059,843.00 |
| Revenue This Year | $61.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.19 |
| 52 Week Low | $0.22 | $0.83 |
| 52 Week High | $8.00 | $6.99 |
Technical Indicators
Market Signals| Indicator | JAGX | MKZR |
|---|---|---|
| Relative Strength Index (RSI) | 16.97 | 45.33 |
| Support Level | $0.29 | $1.37 |
| Resistance Level | $0.46 | $1.84 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 1.27 | 44.44 |
Price Performance
Historical ComparisonAbout JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate. It is a real estate investment manager who utilizes an approach to real estate securities, often seeing opportunities that others overlook. Based in Orinda, California, MacKenzie Capital Management has specialized in discounted real estate securities and asset management.